Virtual Meeting to be held on March 18 hosted by Truist.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLO:
- Allogene Therapeutics’ Earnings Call Highlights Progress
- Promising Pipeline and Upcoming Data Releases Drive Buy Rating for Allogene Therapeutics
- Allogene upgraded to Outperform from Market Perform at Citizens JMP
- Promising Developments in Allogene Therapeutics’ Cema-cel Therapy Highlighted by Phase I Data and Upcoming ALPHA3 Trial
- Promising Potential and Strategic Growth: A Buy Rating for Allogene Therapeutics